Soluble human leukocyte antigen-G expression in hepatitis B virus infection and hepatocellular carcinoma

Tissue Antigens

Volumn 79, Issue 2, 2012, Pages 97-103

  Park, Y ^a,b   Lim, H S ^b   Kim, Y S ^a   Hong, D J ^a   Kim, H S ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Kwandong University College of Medicine   (South Korea)

Author keywords

Cancer diagnosis; Hepatitis B virus; Hepatocellular carcinoma; Human leukocyte antigen G

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA FETOPROTEIN; AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; HLA G ANTIGEN; VIRUS DNA;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CANCER INVASION; CANCER STAGING; CANCER SURGERY; CONTROLLED STUDY; FEMALE; HEPATITIS B; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TUMOR DIFFERENTIATION; TUMOR VOLUME;

ADULT; ALPHA-FETOPROTEINS; ANTIBODIES, VIRAL; AREA UNDER CURVE; BIOLOGICAL MARKERS; CARCINOMA, HEPATOCELLULAR; CARRIER STATE; CASE-CONTROL STUDIES; DNA, VIRAL; FEMALE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HLA-G ANTIGENS; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM GRADING; REPUBLIC OF KOREA; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SOLUBILITY; TRANSAMINASES;

HEPATITIS B VIRUS;

EID: 84855492090     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2011.01814.x     Document Type: Article

References (29)

1. Kovats S, Main EK, Librach C, Stubblebine M, Fisher SJ, DeMars R. A class I antigen, HLA-G, expressed in human trophoblasts. Science 1990: 248: 220-3.
2. Rouas-Freiss N, Naji A, Durrbach A, Carosella ED. Tolerogenic functions of human leukocyte antigen G: from pregnancy to organ and cell transplantation. Transplantation 2007: 84: S21-5.
3. Carosella ED, Moreau P, Le Maoult J, Le Discorde M, Dausset J, Rouas-Freiss N. HLA-G molecules: from maternal-fetal tolerance to tissue acceptance. Adv Immunol 2003: 81: 199-252.
4. Carosella ED, Moreau P, Lemaoult J, Rouas-Freiss N. HLA-G: from biology to clinical benefits. Trends Immunol 2008: 29: 125-32.
5. Colonna M, Navarro F, Bellon T et al. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J Exp Med 1997: 186: 1809-18.
6. Contini P, Ghio M, Poggi A et al. Soluble HLA-A, -B, -C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation. Eur J Immunol 2003: 33: 125-34.
7. Boyson JE, Erskine R, Whitman MC et al. Disulfide bond-mediated dimerization of HLA-G on the cell surface. Proc Natl Acad Sci U S A 2002: 99: 16180-5.
8. Shiroishi M, Kuroki K, Rasubala L et al. Structural basis for recognition of the nonclassical MHC molecule HLA-G by the leukocyte Ig-like receptor B2 (LILRB2/LIR2/ILT4/CD85d). Proc Natl Acad Sci U S A 2006: 103: 16412-7.
9. Donadi EA, Castelli EC, Arnaiz-Villena A, Roger M, Rey D, Moreau P. Implications of the polymorphism of HLA-G on its function, regulation, evolution and disease association. Cell Mol Life Sci 2011: 68: 369-95.
10. Fainardi E, Castellazzi M, Stignani M et al. Emerging topics and new perspectives on HLA-G. Cell Mol Life Sci 2011: 68: 433-51.
11. Shih Ie M. Application of human leukocyte antigen-G expression in the diagnosis of human cancer. Hum Immunol 2007: 68: 272-6.
12. Ye SR, Yang H, Li K, Dong DD, Lin XM, Yie SM. Human leukocyte antigen G expression: as a significant prognostic indicator for patients with colorectal cancer. Mod Pathol 2007: 20: 375-83.
13. Cao M, Yie SM, Liu J, Ye SR, Xia D, Gao E. Plasma soluble HLA-G is a potential biomarker for diagnosis of colorectal, gastric, esophageal and lung cancer. Tissue Antigens 2011: 78: 120-8.
14. Lozano JM, Gonzalez R, Kindelan JM et al. Monocytes and T lymphocytes in HIV-1-positive patients express HLA-G molecule. AIDS 2002: 16: 347-51.
15. Donaghy L, Gros F, Amiot L et al. Elevated levels of soluble non-classical major histocompatibility class I molecule human leucocyte antigen (HLA)-G in the blood of HIV-infected patients with or without visceral leishmaniasis. Clin Exp Immunol 2007: 147: 236-40.
16. Lajoie J, Fontaine J, Tremblay C, Routy JP, Poudrier J, Roger M. Persistence of high levels of blood soluble human leukocyte antigen-G is associated with rapid progression of HIV infection. AIDS 2009: 23: 1437-40.
17. Fabris A, Catamo E, Segat L et al. Association between HLA-G 3′UTR 14-bp polymorphism and HIV vertical transmission in Brazilian children. AIDS 2009: 23: 177-82.
18. Lajoie J, Massinga Loembe M, Poudrier J et al. Blood soluble human leukocyte antigen G levels are associated with human immunodeficiency virus type 1 infection in Beninese commercial sex workers. Hum Immunol 2010: 71: 182-5.
19. Weng PJ, Fu YM, Ding SX, Xu DP, Lin A, Yan WH. Elevation of plasma soluble human leukocyte antigen-G in patients with chronic hepatitis C virus infection. Hum Immunol 2011: 72: 406-11.
20. Chen A, Shen Y, Xia M et al. Expression of the nonclassical HLA class Iand MICA/B molecules in human hepatocellular carcinoma. Neoplasma 2011: 58: 371-6.
21. Foucher J, Chanteloup E, Vergniol J et al. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut 2006: 55: 403-8.
22. Edmondson HA, Steiner PE. Primary carcinoma of the liver: a study of 100 cases among 48, 900 necropsies. Cancer 1954: 7: 462-503.
23. Forner A, Reig ME, de Lope CR, Bruix J. Current strategy for staging and treatment: the BCLC update and future prospects. Semin Liver Dis 2010: 30: 61-74.
24. Wang Y, Ye Z, Meng XQ, Zheng SS. Expression of HLA-G in patients with hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 2011: 10: 158-63.
25. Lin A, Chen HX, Zhu CC et al. Aberrant human leucocyte antigen-G expression and its clinical relevance in hepatocellular carcinoma. J Cell Mol Med 2010: 14: 2162-71.
26. Shi WW, Lin A, Xu DP et al. Plasma soluble human leukocyte antigen-G expression is a potential clinical biomarker in patients with hepatitis B virus infection. Hum Immunol 2011: 72: 1068-73.
27. Cai MY, Xu YF, Qiu SJ et al. Human leukocyte antigen-G protein expression is an unfavorable prognostic predictor of hepatocellular carcinoma following curative resection. Clin Cancer Res 2009: 15: 4686-93.
28. Jiang Y, Chen S, Jia S et al. Association of HLA-G 3′ UTR 14-bp Insertion/Deletion Polymorphism with Hepatocellular Carcinoma Susceptibility in a Chinese Population. DNA Cell Biol 2011. DOI: 10.1089/dna.2011.1238.
29. Souto FJ, Crispim JC, Ferreira SC et al. Liver HLA-G expression is associated with multiple clinical and histopathological forms of chronic hepatitis B virus infection. J Viral Hepat 2011: 18: 102-5.